HIGHLIGHTS
- who: Palavras-chave Tirosina and colleagues from the Centro Hospitalar Universitário Porto, Porto, Portugal have published the research: Objective: Tyrosinemia type III (HT III) is the rarest form of tyrosinemia, and the full clinical spectrum of this disorder is still unknown. The neurological involvement varies, including intellectual impairment and attention deficit disorder with, in the Journal: (JOURNAL)
- what: The authors report the case of two siblings with tyrosinemia type III who were diagnosed and started treatment at different ages, presenting their clinical outcomes.
- future: Studies and collection of information on these patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.